Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.

Wright JK, Novitsky V, Brockman MA, Brumme ZL, Brumme CJ, Carlson JM, Heckerman D, Wang B, Losina E, Leshwedi M, van der Stok M, Maphumulo L, Mkhwanazi N, Chonco F, Goulder PJ, Essex M, Walker BD, Ndung'u T.

J Virol. 2011 Apr;85(8):3996-4006. doi: 10.1128/JVI.02520-10. Epub 2011 Feb 2.

2.

Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.

Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C, Essex M, Mullins JI, Coombs RW, Rees H, Corey L, Wald A; Partners in Prevention HSV/HIV Transmission Study Team.

PLoS One. 2010 Sep 13;5(9):e12598. doi: 10.1371/journal.pone.0012598.

3.

HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission.

Novitsky V, Wang R, Bussmann H, Lockman S, Baum M, Shapiro R, Thior I, Wester C, Wester CW, Ogwu A, Asmelash A, Musonda R, Campa A, Moyo S, van Widenfelt E, Mine M, Moffat C, Mmalane M, Makhema J, Marlink R, Gilbert P, Seage GR 3rd, DeGruttola V, Essex M.

PLoS One. 2010 Apr 12;5(4):e10148. doi: 10.1371/journal.pone.0010148.

4.

Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.

Novitsky V, Wang R, Kebaabetswe L, Greenwald J, Rossenkhan R, Moyo S, Musonda R, Woldegabriel E, Lagakos S, Essex M.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):265-72. doi: 10.1097/QAI.0b013e3181ab6ef0.

5.

CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.

Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, Shattock RJ, Arts EJ.

J Virol. 2009 Jun;83(11):5592-605. doi: 10.1128/JVI.02051-08. Epub 2009 Mar 18.

6.

Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Novitsky V, Woldegabriel E, Kebaabetswe L, Rossenkhan R, Mlotshwa B, Bonney C, Finucane M, Musonda R, Moyo S, Wester C, van Widenfelt E, Makhema J, Lagakos S, Essex M.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):65-76. doi: 10.1097/QAI.0b013e3181900141.

7.

Evolution of proviral gp120 over the first year of HIV-1 subtype C infection.

Novitsky V, Lagakos S, Herzig M, Bonney C, Kebaabetswe L, Rossenkhan R, Nkwe D, Margolin L, Musonda R, Moyo S, Woldegabriel E, van Widenfelt E, Makhema J, Essex M.

Virology. 2009 Jan 5;383(1):47-59. doi: 10.1016/j.virol.2008.09.017. Epub 2008 Oct 29.

8.

Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.

Modjarrad K, Chamot E, Vermund SH.

AIDS. 2008 Oct 18;22(16):2179-85. doi: 10.1097/QAD.0b013e328312c756. Review.

9.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.

PMID:
18677028
10.

HIV-1 transmission, by stage of infection.

Hollingsworth TD, Anderson RM, Fraser C.

J Infect Dis. 2008 Sep 1;198(5):687-93. doi: 10.1086/590501.

PMID:
18662132
11.

Identification of primary HIV-1C infection in Botswana.

Novitsky V, Woldegabriel E, Wester C, McDonald E, Rossenkhan R, Ketunuti M, Makhema J, Seage GR 3rd, Essex M.

AIDS Care. 2008 Aug;20(7):806-11. doi: 10.1080/09540120701694055.

12.

Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection.

Kassutto S, Maghsoudi K, Johnston MN, Robbins GK, Burgett NC, Sax PE, Cohen D, Pae E, Davis B, Zachary K, Basgoz N, D'agata EM, DeGruttola V, Walker BD, Rosenberg ES.

Clin Infect Dis. 2006 Apr 1;42(7):1024-31. Epub 2006 Feb 27.

PMID:
16511771
13.

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC.

J Infect Dis. 2005 May 1;191(9):1403-9. Epub 2005 Mar 30.

PMID:
15809897
14.

Frequent detection of acute primary HIV infection in men in Malawi.

Pilcher CD, Price MA, Hoffman IF, Galvin S, Martinson FE, Kazembe PN, Eron JJ, Miller WC, Fiscus SA, Cohen MS.

AIDS. 2004 Feb 20;18(3):517-24.

PMID:
15090805
15.

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP.

AIDS. 2003 Sep 5;17(13):1871-9.

PMID:
12960819
16.

Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.

Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, QuiƱones-Mateu ME, Penn-Nicholson A, Murray M, Richard N, Lobritz M, Zimmerman PA, Kawamura T, Blauvelt A, Arts EJ.

J Virol. 2003 Jan;77(2):1021-38.

17.

Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women.

Lavreys L, Baeten JM, Overbaugh J, Panteleeff DD, Chohan BH, Richardson BA, Mandaliya K, Ndinya-Achola JO, Kreiss JK.

Clin Infect Dis. 2002 Jul 1;35(1):77-81. Epub 2002 Jun 3.

PMID:
12060878
18.

Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand.

Tovanabutra S, Robison V, Wongtrakul J, Sennum S, Suriyanon V, Kingkeow D, Kawichai S, Tanan P, Duerr A, Nelson KE.

J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):275-83.

PMID:
11873077
19.

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, Mulenga J, Kasolo F, Vermund SH, Aldrovandi GM.

AIDS Res Hum Retroviruses. 2001 Jul 1;17(10):901-10.

20.

Primary HIV-1 infection: a review of clinical manifestations, immunologic and virologic changes.

Kaufmann GR, Duncombe C, Zaunders J, Cunningham P, Cooper D.

AIDS Patient Care STDS. 1998 Oct;12(10):759-67. Review.

PMID:
11362020

Supplemental Content

Support Center